The global Basic Infusion market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Basic Infusion is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Basic Infusion is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Basic Infusion include Baxter, B. Braun, Fresenius Kabi, Kelun Pharma, Otsuka Pharmaceutical, JW Pharmaceutical, Pfizer, Teva Pharmaceutical and Haisco Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Basic Infusion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Basic Infusion.
Report Scope
The Basic Infusion market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Basic Infusion market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Basic Infusion manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi'an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli
Segment by Type
Glucose
Sodium Chloride
Compound Product
Segment by Application
max. 100ml
250ml
500ml
min. 1L
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Basic Infusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Basic Infusion in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Basic Infusion Market Overview
1.1 Product Overview and Scope of Basic Infusion
1.2 Basic Infusion Segment by Type
1.2.1 Global Basic Infusion Market Value Comparison by Type (2024-2030)
1.2.2 Glucose
1.2.3 Sodium Chloride
1.2.4 Compound Product
1.3 Basic Infusion Segment by Application
1.3.1 Global Basic Infusion Market Value by Application: (2024-2030)
1.3.2 max. 100ml
1.3.3 250ml
1.3.4 500ml
1.3.5 min. 1L
1.4 Global Basic Infusion Market Size Estimates and Forecasts
1.4.1 Global Basic Infusion Revenue 2019-2030
1.4.2 Global Basic Infusion Sales 2019-2030
1.4.3 Global Basic Infusion Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Basic Infusion Market Competition by Manufacturers
2.1 Global Basic Infusion Sales Market Share by Manufacturers (2019-2024)
2.2 Global Basic Infusion Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Basic Infusion Average Price by Manufacturers (2019-2024)
2.4 Global Basic Infusion Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Basic Infusion, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Basic Infusion, Product Type & Application
2.7 Basic Infusion Market Competitive Situation and Trends
2.7.1 Basic Infusion Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Basic Infusion Players Market Share by Revenue
2.7.3 Global Basic Infusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Basic Infusion Retrospective Market Scenario by Region
3.1 Global Basic Infusion Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Basic Infusion Global Basic Infusion Sales by Region: 2019-2030
3.2.1 Global Basic Infusion Sales by Region: 2019-2024
3.2.2 Global Basic Infusion Sales by Region: 2025-2030
3.3 Global Basic Infusion Global Basic Infusion Revenue by Region: 2019-2030
3.3.1 Global Basic Infusion Revenue by Region: 2019-2024
3.3.2 Global Basic Infusion Revenue by Region: 2025-2030
3.4 North America Basic Infusion Market Facts & Figures by Country
3.4.1 North America Basic Infusion Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Basic Infusion Sales by Country (2019-2030)
3.4.3 North America Basic Infusion Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Basic Infusion Market Facts & Figures by Country
3.5.1 Europe Basic Infusion Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Basic Infusion Sales by Country (2019-2030)
3.5.3 Europe Basic Infusion Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Basic Infusion Market Facts & Figures by Country
3.6.1 Asia Pacific Basic Infusion Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Basic Infusion Sales by Country (2019-2030)
3.6.3 Asia Pacific Basic Infusion Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Basic Infusion Market Facts & Figures by Country
3.7.1 Latin America Basic Infusion Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Basic Infusion Sales by Country (2019-2030)
3.7.3 Latin America Basic Infusion Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Basic Infusion Market Facts & Figures by Country
3.8.1 Middle East and Africa Basic Infusion Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Basic Infusion Sales by Country (2019-2030)
3.8.3 Middle East and Africa Basic Infusion Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Basic Infusion Sales by Type (2019-2030)
4.1.1 Global Basic Infusion Sales by Type (2019-2024)
4.1.2 Global Basic Infusion Sales by Type (2025-2030)
4.1.3 Global Basic Infusion Sales Market Share by Type (2019-2030)
4.2 Global Basic Infusion Revenue by Type (2019-2030)
4.2.1 Global Basic Infusion Revenue by Type (2019-2024)
4.2.2 Global Basic Infusion Revenue by Type (2025-2030)
4.2.3 Global Basic Infusion Revenue Market Share by Type (2019-2030)
4.3 Global Basic Infusion Price by Type (2019-2030)
5 Segment by Application
5.1 Global Basic Infusion Sales by Application (2019-2030)
5.1.1 Global Basic Infusion Sales by Application (2019-2024)
5.1.2 Global Basic Infusion Sales by Application (2025-2030)
5.1.3 Global Basic Infusion Sales Market Share by Application (2019-2030)
5.2 Global Basic Infusion Revenue by Application (2019-2030)
5.2.1 Global Basic Infusion Revenue by Application (2019-2024)
5.2.2 Global Basic Infusion Revenue by Application (2025-2030)
5.2.3 Global Basic Infusion Revenue Market Share by Application (2019-2030)
5.3 Global Basic Infusion Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Basic Infusion Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 B. Braun
6.2.1 B. Braun Corporation Information
6.2.2 B. Braun Description and Business Overview
6.2.3 B. Braun Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.2.4 B. Braun Basic Infusion Product Portfolio
6.2.5 B. Braun Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius Kabi Basic Infusion Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Kelun Pharma
6.4.1 Kelun Pharma Corporation Information
6.4.2 Kelun Pharma Description and Business Overview
6.4.3 Kelun Pharma Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kelun Pharma Basic Infusion Product Portfolio
6.4.5 Kelun Pharma Recent Developments/Updates
6.5 Otsuka Pharmaceutical
6.5.1 Otsuka Pharmaceutical Corporation Information
6.5.2 Otsuka Pharmaceutical Description and Business Overview
6.5.3 Otsuka Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Otsuka Pharmaceutical Basic Infusion Product Portfolio
6.5.5 Otsuka Pharmaceutical Recent Developments/Updates
6.6 JW Pharmaceutical
6.6.1 JW Pharmaceutical Corporation Information
6.6.2 JW Pharmaceutical Description and Business Overview
6.6.3 JW Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.6.4 JW Pharmaceutical Basic Infusion Product Portfolio
6.6.5 JW Pharmaceutical Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Basic Infusion Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Teva Pharmaceutical
6.8.1 Teva Pharmaceutical Corporation Information
6.8.2 Teva Pharmaceutical Description and Business Overview
6.8.3 Teva Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Pharmaceutical Basic Infusion Product Portfolio
6.8.5 Teva Pharmaceutical Recent Developments/Updates
6.9 Haisco Pharmaceutical Group
6.9.1 Haisco Pharmaceutical Group Corporation Information
6.9.2 Haisco Pharmaceutical Group Description and Business Overview
6.9.3 Haisco Pharmaceutical Group Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Haisco Pharmaceutical Group Basic Infusion Product Portfolio
6.9.5 Haisco Pharmaceutical Group Recent Developments/Updates
6.10 King York
6.10.1 King York Corporation Information
6.10.2 King York Description and Business Overview
6.10.3 King York Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.10.4 King York Basic Infusion Product Portfolio
6.10.5 King York Recent Developments/Updates
6.11 Cisen
6.11.1 Cisen Corporation Information
6.11.2 Cisen Basic Infusion Description and Business Overview
6.11.3 Cisen Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cisen Basic Infusion Product Portfolio
6.11.5 Cisen Recent Developments/Updates
6.12 Lummy
6.12.1 Lummy Corporation Information
6.12.2 Lummy Basic Infusion Description and Business Overview
6.12.3 Lummy Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Lummy Basic Infusion Product Portfolio
6.12.5 Lummy Recent Developments/Updates
6.13 Grand Life Sciences
6.13.1 Grand Life Sciences Corporation Information
6.13.2 Grand Life Sciences Basic Infusion Description and Business Overview
6.13.3 Grand Life Sciences Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Grand Life Sciences Basic Infusion Product Portfolio
6.13.5 Grand Life Sciences Recent Developments/Updates
6.14 Medisan
6.14.1 Medisan Corporation Information
6.14.2 Medisan Basic Infusion Description and Business Overview
6.14.3 Medisan Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Medisan Basic Infusion Product Portfolio
6.14.5 Medisan Recent Developments/Updates
6.15 BBCA Pharmaceutical
6.15.1 BBCA Pharmaceutical Corporation Information
6.15.2 BBCA Pharmaceutical Basic Infusion Description and Business Overview
6.15.3 BBCA Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.15.4 BBCA Pharmaceutical Basic Infusion Product Portfolio
6.15.5 BBCA Pharmaceutical Recent Developments/Updates
6.16 Biokin Pharmaceutical
6.16.1 Biokin Pharmaceutical Corporation Information
6.16.2 Biokin Pharmaceutical Basic Infusion Description and Business Overview
6.16.3 Biokin Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Biokin Pharmaceutical Basic Infusion Product Portfolio
6.16.5 Biokin Pharmaceutical Recent Developments/Updates
6.17 Xi'an Libang Pharmaceutical
6.17.1 Xi'an Libang Pharmaceutical Corporation Information
6.17.2 Xi'an Libang Pharmaceutical Basic Infusion Description and Business Overview
6.17.3 Xi'an Libang Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Xi'an Libang Pharmaceutical Basic Infusion Product Portfolio
6.17.5 Xi'an Libang Pharmaceutical Recent Developments/Updates
6.18 Lionco Pharmaceutical
6.18.1 Lionco Pharmaceutical Corporation Information
6.18.2 Lionco Pharmaceutical Basic Infusion Description and Business Overview
6.18.3 Lionco Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Lionco Pharmaceutical Basic Infusion Product Portfolio
6.18.5 Lionco Pharmaceutical Recent Developments/Updates
6.19 China Meheco Kangli
6.19.1 China Meheco Kangli Corporation Information
6.19.2 China Meheco Kangli Basic Infusion Description and Business Overview
6.19.3 China Meheco Kangli Basic Infusion Sales, Revenue and Gross Margin (2019-2024)
6.19.4 China Meheco Kangli Basic Infusion Product Portfolio
6.19.5 China Meheco Kangli Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Basic Infusion Industry Chain Analysis
7.2 Basic Infusion Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Basic Infusion Production Mode & Process
7.4 Basic Infusion Sales and Marketing
7.4.1 Basic Infusion Sales Channels
7.4.2 Basic Infusion Distributors
7.5 Basic Infusion Customers
8 Basic Infusion Market Dynamics
8.1 Basic Infusion Industry Trends
8.2 Basic Infusion Market Drivers
8.3 Basic Infusion Market Challenges
8.4 Basic Infusion Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi'an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli
听
听
*If Applicable.